Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review

Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?

(2013) Victor M. Montori   ANNALS OF INTERNAL MEDICINE

Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease

(2012) Kathleen Stergiopoulos   ARCHIVES OF INTERNAL MEDICINE

Reversals of Established Medical Practices

(2012) Vinay Prasad et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Industry Support of CME — Are We at the Tipping Point?

(2012) Michael A. Steinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?

(2012) P. C. Gotzsche et al.   BMJ-British Medical Journal

Conflicts of Interest in Cardiovascular Clinical Practice Guidelines

(2011) Todd B. Mendelson et al.   ARCHIVES OF INTERNAL MEDICINE

Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test

(2011) N. P. Polyzos et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments

(2011) Michelle Roseman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lessons from Lipitor and the broken blockbuster drug model

(2011) The Lancet   LANCET

Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review

(2011) Susan L. Norris et al.   PLoS One

Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review

(2011) Kirsten E. Austad et al.   PLOS MEDICINE

Meta-research: The art of getting it wrong

(2011) John P. A. Ioannidis   Research Synthesis Methods

The Impact of Disclosing Financial Ties in Research and Clinical Care

(2010) Adam Licurse   ARCHIVES OF INTERNAL MEDICINE

Funding for Medical Education: Maintaining a Healthy Separation From Industry

(2010) Jerry Avorn et al.   CIRCULATION

Intensified glucose lowering in type 2 diabetes: time for a reappraisal

(2010) J. S. Yudkin et al.   DIABETOLOGIA

Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians

(2010) G. K. Silverman et al.   JOURNAL OF MEDICAL ETHICS

Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®)

(2010) Mark H. Rozenbaum et al.   VACCINE

Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study

(2010) Andreas Lundh et al.   PLOS MEDICINE

Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences

(2009) David Grande et al.   ARCHIVES OF INTERNAL MEDICINE

Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid

(2009) Michael R. Law   ARCHIVES OF INTERNAL MEDICINE

Key opinion leaders: where they come from and how that affects the drugs you prescribe

(2009) Jeffrey J. Meffert   Dermatologic Therapy

Industry sponsorship and selection of comparators in randomized clinical trials

(2009) D. N. Lathyris et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines

(2009) Pierluigi Tricoci   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmaceutical Industry Financial Support for Medical Education: Benefit, or Undue Influence?

(2009) Howard Brody   JOURNAL OF LAW MEDICINE & ETHICS

Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use

(2009) S. Swaroop Vedula et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ghosts in the Machine

(2009) Sergio Sismondo   SOCIAL STUDIES OF SCIENCE

Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease

(2008) Aaron S. Kesselheim   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Guest Authorship and Ghostwriting in Publications Related to Rofecoxib

(2008) Joseph S. Ross et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Key opinion leaders: independent experts or drug representatives in disguise?

(2008) Ray Moynihan   BMJ-British Medical Journal

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States

(2007) Marc-André Gagnon et al.   PLOS MEDICINE